Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2015 1
2016 3
2017 4
2018 5
2019 3
2020 5
2021 8
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
Tanifuji A, Ohfuji S, Matsumoto K, Abe M, Komori A, Takahashi A, Kawata K, Sato K, Joshita S, Umemura T, Ueno M, Nakayama N, Kakisaka K, Arinaga-Hino T, Ito K, Kanai S, Miura R, Arizumi T, Asaoka Y, Ito T, Shimizu T, Yoshida H, Ohta M, Mizuno S, Isayama H, Morimoto Y, Mochida S, Ohira H, Tanaka A. Tanifuji A, et al. Among authors: arinaga hino t. Hepatol Res. 2024 Feb 1. doi: 10.1111/hepr.14018. Online ahead of print. Hepatol Res. 2024. PMID: 38300669
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Sano T, Amano K, Ide T, Isoda H, Honma Y, Morita Y, Yano Y, Nakamura H, Itano S, Miyajima I, Shirachi M, Kuwahara R, Ohno M, Kawaguchi T, Tsutsumi T, Nakano D, Arinaga-Hino T, Kawaguchi M, Eguchi Y, Torimura T, Takahashi H, Harada M, Kawaguchi T; SAKS Study Group. Sano T, et al. Among authors: arinaga hino t. Hepatol Res. 2024 Apr;54(4):326-335. doi: 10.1111/hepr.13993. Epub 2023 Nov 28. Hepatol Res. 2024. PMID: 37975277
Clinicopathologic Features, Genetics, Treatment, and Long-Term Outcomes in Japanese Children and Young Adults with Benign Recurrent Intrahepatic Cholestasis: A Multicenter Study.
Kato K, Umetsu S, Togawa T, Ito K, Kawabata T, Arinaga-Hino T, Tsumura N, Yasuda R, Mihara Y, Kusano H, Ito S, Imagawa K, Hayashi H, Inui A, Yamashita Y, Mizuochi T. Kato K, et al. Among authors: arinaga hino t. J Clin Med. 2023 Sep 15;12(18):5979. doi: 10.3390/jcm12185979. J Clin Med. 2023. PMID: 37762919 Free PMC article.
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.
Gatselis NK, Zachou K, Loza AJM, Cançado ELR, Arinaga-Hino T, Muratori P, Efe C, Floreani A, Invernizzi P, Takahashi A, Takaki A, Beretta-Piccoli BT, van Hoek B, Lytvyak E, Guedes LV, Purnak T, Cazzagon N, Lygoura V, Arvaniti P, Rigopoulou EI, Muratori L, Dalekos GN; International Autoimmune Hepatitis Group. Gatselis NK, et al. Among authors: arinaga hino t. Eur J Intern Med. 2023 Oct;116:43-50. doi: 10.1016/j.ejim.2023.06.001. Epub 2023 Jun 10. Eur J Intern Med. 2023. PMID: 37302951
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Sano T, Amano K, Ide T, Yokoyama K, Noguchi K, Nakamura H, Isoda H, Ohno M, Shirachi M, Morita Y, Yano Y, Sumie S, Kawaguchi T, Kuwahara R, Arinaga-Hino T, Takahashi H, Shakado S, Hirai F, Kawaguchi T. Sano T, et al. Among authors: arinaga hino t. Hepatol Res. 2023 Jan;53(1):26-34. doi: 10.1111/hepr.13837. Epub 2022 Sep 20. Hepatol Res. 2023. PMID: 36066400
Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1.
Suzuki H, Arinaga-Hino T, Sano T, Mihara Y, Kusano H, Mizuochi T, Togawa T, Ito S, Ide T, Kuwahara R, Amano K, Kawaguchi T, Yano H, Kage M, Koga H, Torimura T. Suzuki H, et al. Among authors: arinaga hino t. Front Med (Lausanne). 2022 Apr 29;9:891659. doi: 10.3389/fmed.2022.891659. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572954 Free PMC article.
Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer.
Kuromatsu R, Ide T, Okamura S, Noda Y, Kamachi N, Nakano M, Shirono T, Shimose S, Iwamoto H, Kuwahara R, Arinaga-Hino T, Niizeki T, Zaizen Y, Takaki H, Shirachi M, Koga H, Torimura T. Kuromatsu R, et al. Among authors: arinaga hino t. Cancers (Basel). 2022 May 4;14(9):2295. doi: 10.3390/cancers14092295. Cancers (Basel). 2022. PMID: 35565424 Free PMC article.
Clinical practice guidelines for autoimmune hepatitis.
Ohira H, Takahashi A, Zeniya M, Abe M, Arinaga-Hino T, Joshita S, Takaki A, Nakamoto N, Kang JH, Suzuki Y, Sogo T, Inui A, Koike K, Harada K, Nakamoto Y, Kondo Y, Genda T, Tsuneyama K, Matsui T, Tanaka A. Ohira H, et al. Among authors: arinaga hino t. Hepatol Res. 2022 Jul;52(7):571-585. doi: 10.1111/hepr.13776. Epub 2022 May 25. Hepatol Res. 2022. PMID: 35533021 No abstract available.
Risk factors for relapse of autoimmune hepatitis in Japan: A nationwide survey.
Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, Nakamoto N, Takaki A, Kang JH, Joshita S, Suzuki Y, Koike K, Inui A, Tanaka A; Japan Autoimmune Hepatitis Study Group. Takahashi A, et al. Among authors: arinaga hino t. Hepatol Res. 2022 Jul;52(7):597-602. doi: 10.1111/hepr.13766. Epub 2022 Apr 13. Hepatol Res. 2022. PMID: 35355374
35 results